Company Statement: Teva and Cephalon receive FTC request for additional information
MLex Summary: Teva Pharmaceutical Industries and Cephalon announced that they have received a request for additional information from the Federal Trade Commission in connection with Teva's pending buyout of Cephalon. The companies intend to continue to cooperate with the FTC...To view the full article, register now.
Already a subscriber? Click here to view full article